Optimizing Multidisciplinary Care in CKD Screening

Optimizing care for patients with CKD and multiple comorbidities requires close coordination between cardiology, nephrology, and primary care, with an emphasis on early identification of kidney impairment. Detecting CKD early is crucial because timely intervention can slow disease progression, reduce cardiovascular complications, and guide safer medication choices. Cardiologists commonly use ACE inhibitors or ARBs, SGLT2 inhibitors, GLP-1 receptor agonists, mineralocorticoid receptor antagonists, and statins to address intertwined cardiac and renal risks. From a primary care standpoint, early CKD detection enables risk stratification, lifestyle counseling, and initiation of kidney-protective therapies before irreversible damage occurs. Balancing screening with other preventive priorities involves embedding routine eGFR and uACR testing into annual labs for high-risk patients, using clinical decision support to flag abnormalities, and leveraging team-based care to ensure that CKD management complements broader preventive health goals.